MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program
Publication
, Conference
Xu-Monette, ZY; Tzankov, A; Li, Y; Visco, C; Montes-Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Huh, J ...
Published in: BLOOD
November 15, 2013
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2013
Volume
122
Issue
21
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
55th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu-Monette, Z. Y., Tzankov, A., Li, Y., Visco, C., Montes-Moreno, S., Dybkaer, K., … Young, K. H. (2013). MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program. In BLOOD (Vol. 122). New Orleans, LA: AMER SOC HEMATOLOGY.
Xu-Monette, Zijun Y., Alexander Tzankov, Yong Li, Carlo Visco, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, et al. “MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program.” In BLOOD, Vol. 122. AMER SOC HEMATOLOGY, 2013.
Xu-Monette ZY, Tzankov A, Li Y, Visco C, Montes-Moreno S, Dybkaer K, et al. MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program. In: BLOOD. AMER SOC HEMATOLOGY; 2013.
Xu-Monette, Zijun Y., et al. “MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program.” BLOOD, vol. 122, no. 21, AMER SOC HEMATOLOGY, 2013.
Xu-Monette ZY, Tzankov A, Li Y, Visco C, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, Van Krieken JHJM, Huh J, Ai WZ, Ponzoni M, Ferreri AJM, Farnen JP, Moller MB, Winter JN, Piris MA, Medeiros LJ, Young KH. MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program. BLOOD. AMER SOC HEMATOLOGY; 2013.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2013
Volume
122
Issue
21
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
55th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology